Key result
CAD polygenic risk score is linked to ~24% higher major cardiovascular events risk and improves risk classification.
Why the study?
Does the addition of cardiometabolic polygenic risk scores improve the prediction of incident major adverse cardiovascular events in adults aged 40 to 69 years?
Cohort (n=487,151)
Does the addition of cardiometabolic polygenic risk scores improve the prediction of incident major adverse cardiovascular events in adults aged 40 to 69 years?
Answers are grounded in this paper and cite their sources.
The integration of cardiometabolic polygenic risk scores into risk prediction models significantly improves the classification and prediction of major adverse cardiovascular events, particularly in younger individuals.
Background Genetic profiling with polygenic risk scores (PRS) may enable earlier and more targeted intervention reducing the risk of major adverse cardiovascular events (MACE). There is emerging evidence of the potential value of implementing cardiovascular disease PRS into healthcare systems and ongoing efforts to integrate these into risk assessment programmes in the UK. Purpose This study examined the associations and clinical utilities of demographic, lifestyle, clinical and cardiometabolic genetic risk factors on MACE. Methods 487,151 UK Biobank participants aged 40 to 69 years were included. Cardiometabolic PRS for smoking, alcohol intake, body mass index (BMI), waist to hip ratio (WHR), blood pressure, blood lipids, blood glucose, glycated haemoglobin (HbA1c), lipoprotein (a)(Lp(a)), diabetes and coronary artery disease (CAD) were calculated using published genome-wide association summary data and individual genotype information. Cox proportional hazards regressions modelled associations of age at enrolment, sex, lipid-lowering therapy, cigarette smoking, Townsend index, WHR, HbA1c, BMI, blood pressure, blood lipids, blood glucose, novel risk factors (physical activity, diet, alcohol intake, sleep, Lp(a), C-reactive protein, estimated glomerular filtration rate (eGFR)), and cardiometabolic PRSs with MACE. MACE was defined as myocardial infarction and/or stroke either fatal or non-fatal. The discriminative effect of non-genetic risk factors on MACE was compared with cardiometabolic PRSs and non-genetic risk factors using the C-index and net reclassification index (NRI). C-index and NRI were evaluated across different age groups. Results Of the genetic risk factors investigated, CAD PRS is the strongest predictor of MACE (HR 1.24, 95% CI 1.23-1.25). Age, male sex, lipid-lowering therapy, Townsend index, BMI, WHR, LDL, HDL, blood glucose, HbA1c, C-reactive protein, eGFR, Lp(a), diet, alcohol intake, sleep, and multiple PRS variables including CAD PRS were all independently associated with MACE. The addition of all PRSs to a model with established and novel risk factors improved the C-index from 0.7715 (95% CI 0.7698 to 0.7732) to 0.7767 (95% CI 0.7750 to 0.7784) (Figure 1). The addition of all PRSs to a model with established and novel risk factors substantially improved MACE classification with a NRI of 20% in the whole cohort and a NRI of 24% in those less than 50 years (Figure 2). Conclusions Our study is the first to investigate a wider range of genetic risk factors for MACE, with evaluation of twelve separate cardiometabolic PRSs. Clinical, laboratory and demographic factors are individually associated with MACE. Genetic risk profile enhances the precision of risk prediction especially in younger age groups and can be added to risk prediction models. This can be used in younger age groups to implement lifestyle interventions and target preventive medications in those with the highest cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Shyam-Sundar et al. (2025) conducted a cohort in Major adverse cardiovascular events (MACE) (n=487,151). Cardiometabolic polygenic risk scores (PRS) vs. Established and novel clinical risk factors was evaluated on MACE (myocardial infarction and/or stroke either fatal or non-fatal) (HR 1.24, 95% CI 1.23-1.25). Coronary artery disease polygenic risk score was the strongest genetic predictor of major cardiovascular events, and adding all PRSs to established risk factors improved major cardiovascular events classification.
Synapse has enriched 10 related papers. Consider them for comparative context: